Copyright © Inderes 2011 - present. All rights reserved.
Log in to receive notifications.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Prolight Diagnostics

0.388

 

SEK

 

-1.77 %

Less than 1K followers

PRLD

Nordic SME

Medical Equipment & Services

Health Care

Overview
Ownership
Investor consensus
Compare
-1.77%
-21.3%
+72.44%
+189.55%
+171.33%
+160.4%
+21.63%
-83.49%
-9.77%

Prolight Diagnostics develops test systems in POCT (Point of care testing). The tests are used outside of hospital laboratories to enable rapid assessments of the health of patients. The company's POCT platform is under development with the intention of measuring various biomarkers simultaneously. An important component of the work is to reduce the time for test results, particularly important for patients with heart problems. The company was founded in 1999 and is based in Lund.

Read more
Market cap
272.41M SEK
Turnover
499.98K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
30/5
2025

Interim report Q1'25

24/6
2025

General meeting '25

28/8
2025

Interim report Q2'25

All
Webcasts
Press releases
3rd party
ShowingAll content types
Press release5/9/2025, 6:00 AM

Prolight får nytt MicroFlex-patent godkänt i USA

Prolight Diagnostics
Press release5/9/2025, 6:00 AM

Prolight receives new MicroFlex patent approval in the US

Prolight Diagnostics
Press release4/28/2025, 6:00 AM

Prolight erhåller sina två första europeiska patent för Psyros™-teknologin

Prolight Diagnostics

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release4/28/2025, 6:00 AM

Prolight secures first two European patents for Psyros™ technology

Prolight Diagnostics
Press release4/23/2025, 8:45 AM

Studie visar hur snabbt biomarkörer kan integreras på Psyros POC-plattform

Prolight Diagnostics
Press release4/23/2025, 8:45 AM

Study highlights speed of biomarker integration on Psyros POC platform

Prolight Diagnostics
Third party research4/1/2025, 7:38 AM

Prolight: Positive results from the pre-clinical validation study de-risk the full clinical validation - Emergers

Following the many recent grants, notices of allowance and intention to grant patents in Europe and the US, and the arrival of the first of thirty commercial prototype instruments for the Psyros Point of Care (POC) system, Prolight has now announced ...

Prolight Diagnostics
Press release4/1/2025, 7:05 AM

EMERGERS PUBLICERAR UPPDATERAD ANALYS OM PROLIGHT DIAGNOSTICS

Prolight Diagnostics
Press release4/1/2025, 6:00 AM

Emergers: Equity Research | PROLIGHT: Positive results from the pre-clinical validation study de-risk the full clinical validation

Prolight Diagnostics
Regulatory press release3/31/2025, 6:00 AM

Prolight meddelar positiva prekliniska data

Prolight Diagnostics
Regulatory press release3/31/2025, 6:00 AM

Prolight announces positive pre-clinical data

Prolight Diagnostics
Press release3/26/2025, 7:00 AM

Prolight erhåller notice of allowance för MicroFlex-patent

Prolight Diagnostics
Press release3/26/2025, 7:00 AM

Prolight receives notice of allowance for MicroFlex patent

Prolight Diagnostics
Press release3/13/2025, 7:00 AM

The Psyros™ Cartridge Pilot Manufacturing line achieves another milestone!

Prolight Diagnostics
Press release3/13/2025, 7:00 AM

Psyros™ Pilotproduktionslinje av testkort når ytterligare en milstolpe!

Prolight Diagnostics
Regulatory press release2/28/2025, 8:50 AM

Prolight Diagnostics publicerar bokslutskommuniké 2024

Prolight Diagnostics
Regulatory press release2/28/2025, 8:50 AM

Prolight Diagnostics publishes year-end report 2024

Prolight Diagnostics
Press release2/19/2025, 7:00 AM

Prolight får sitt andra positiva patentbesked för Psyros™-teknologin

Prolight Diagnostics
Press release2/19/2025, 7:00 AM

Prolight receives second Notice of Intention to Grant from European Patent Office for Psyros™ technology

Prolight Diagnostics
Press release2/18/2025, 7:00 AM

Prolight får positivt patentbesked för kärnpatent för Psyros™

Prolight Diagnostics
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team